ClinVar Miner

Submissions for variant NM_000414.4(HSD17B4):c.1138A>G (p.Ile380Val)

gnomAD frequency: 0.00034  dbSNP: rs137946207
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000729881 SCV000857574 uncertain significance not provided 2017-10-16 criteria provided, single submitter clinical testing
GeneDx RCV000729881 SCV001813312 likely benign not provided 2021-03-31 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 28649525)
Labcorp Genetics (formerly Invitae), Labcorp RCV002060984 SCV002468192 likely benign Bifunctional peroxisomal enzyme deficiency; Perrault syndrome 2024-01-03 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004535828 SCV004116581 uncertain significance HSD17B4-related disorder 2024-03-26 no assertion criteria provided clinical testing The HSD17B4 c.1138A>G variant is predicted to result in the amino acid substitution p.Ile380Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.088% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.